Your browser doesn't support javascript.
loading
Venetoclax Combined with Azacitidine and Homoharringtonine in Relapsed/Refractory AML: A Multicenter, Phase 2 Trial.
Jin, Hua; Zhang, Yu; Yu, Sijian; Du, Xin; Xu, Na; Shao, Ruoyang; Lin, Dongjun; Chen, Yanqiu; Xiao, Jie; Sun, Zhiqiang; Deng, Lan; Liang, Xinquan; Zhang, Hongyu; Guo, Ziwen; Dai, Min; Shi, Pengcheng; Huang, Fen; Fan, Zhiping; Yin, Zhao; Xuan, Li; Lin, Ren; Jiang, Xuejie; Yu, Guopan; Liu, Qifa.
Affiliation
  • Jin H; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Zhang Y; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Yu S; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Du X; Department of Hematology and Shenzhen Bone Marrow Transplantation Public Service Platform, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China.
  • Xu N; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Shao R; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Lin D; Department of Hematology, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, China.
  • Chen Y; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Xiao J; Department of Hematology, Maoming People's Hospital, Maoming, China.
  • Sun Z; Department of Hematology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Deng L; Department of Hematology, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
  • Liang X; Department of Hematology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhang H; Department of Hematology, The First People's Hospital of Chenzhou, Chenzhou, China.
  • Guo Z; Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, China.
  • Dai M; Department of Hematology, Zhongshan City People's Hospital, Zhongshan, China.
  • Shi P; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Huang F; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Fan Z; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Yin Z; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Xuan L; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Lin R; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Jiang X; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Yu G; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Liu Q; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China. yugpp@163.com.
J Hematol Oncol ; 16(1): 42, 2023 04 29.
Article in En | MEDLINE | ID: mdl-37120593
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azacitidine / Leukemia, Myeloid, Acute Type of study: Clinical_trials Limits: Humans Language: En Journal: J Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2023 Document type: Article Affiliation country: China Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azacitidine / Leukemia, Myeloid, Acute Type of study: Clinical_trials Limits: Humans Language: En Journal: J Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2023 Document type: Article Affiliation country: China Country of publication: United kingdom